Bradley Saenger

Insider Reports History

Location
New York, NY
Signature
/s/ Bradley Saenger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bradley Saenger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tonix Pharmaceuticals Holding Corp. Chief Financial Officer Common Stock, par value $0.001 701 $9,407 $13.42 31 Dec 2025 Direct
Tonix Pharmaceuticals Holding Corp. Chief Financial Officer Stock Option 39,011 24 Feb 2026 Direct

Insider Reports Filed by Bradley Saenger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNXP Tonix Pharmaceuticals Holding Corp. 24 Feb 2026 2 $0 4 Chief Financial Officer 26 Feb 2026, 07:03
TNXP Tonix Pharmaceuticals Holding Corp. 31 Dec 2025 1 +$9,407 5 Chief Financial Officer, 10%+ Owner 17 Feb 2026, 07:00
TNXP Tonix Pharmaceuticals Holding Corp. 05 Feb 2025 3 $0 4 Chief Financial Officer 27 Feb 2025, 18:51
TNXP Tonix Pharmaceuticals Holding Corp. 27 Feb 2024 2 $0 4 Chief Financial Officer 29 Feb 2024, 17:07
TNXP Tonix Pharmaceuticals Holding Corp. 23 Feb 2023 2 $0 4 Chief Financial Officer 24 Feb 2023, 17:37
TNXP Tonix Pharmaceuticals Holding Corp. 15 Feb 2022 4 $0 4 Chief Financial Officer 17 Feb 2022, 16:19
TNXP Tonix Pharmaceuticals Holding Corp. 31 Dec 2021 1 +$10,584 5 Chief Financial Officer 11 Feb 2022, 16:18